ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

EDEN Eden Research Plc

4.125
-0.125 (-2.94%)
Last Updated: 09:42:22
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Eden Research Plc LSE:EDEN London Ordinary Share GB0001646941 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.125 -2.94% 4.125 4.00 4.25 4.25 4.125 4.25 159,730 09:42:22
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 1.83M -2.24M -0.0042 -11.90 26.67M
Eden Research Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker EDEN. The last closing price for Eden Research was 4.25p. Over the last year, Eden Research shares have traded in a share price range of 3.20p to 12.00p.

Eden Research currently has 533,352,523 shares in issue. The market capitalisation of Eden Research is £26.67 million. Eden Research has a price to earnings ratio (PE ratio) of -11.90.

Eden Research Share Discussion Threads

Showing 3326 to 3342 of 17950 messages
Chat Pages: Latest  142  141  140  139  138  137  136  135  134  133  132  131  Older
DateSubjectAuthorDiscuss
11/12/2017
12:45
Lykele van der Broek seems to think it will and he's one of the smartest fellas in the industry.
supersonico
11/12/2017
12:44
supersonico, I think you've covered it :)
investingisatrickygame
11/12/2017
12:35
So much potential....will it ever be realised?
littlealbatross2
10/12/2017
20:19
Eden Gets Growing - (EDEN)
29/9/2017 (119264)

Eden Gets Growing

As ever, investing in Eden Research (EDEN) requires patience. Interim results for the first half of 2016 disappointed the market, and the shares slipped, closing at 11p to 11.75p in a little flurry of selling after rising to 13p.

Perhaps an updated note from house broker Shore Capital did the damage. Headlined ‘A vote of confidence’ and taking encouragement from the £2.2m investment in a 9.9% stake by Sipcam, the note repeated earlier predictions of revenues for 2016 at £1.7m with pre-tax losses of £1.5m, and went on to suggest there would still be a small loss by 2020, though revenues could have risen to £5.7m by then.

While these figures are estimated on a conservative basis, using only contracted deals, they must bring a weary sigh from investors who have believed that Eden’s all natural terpene technology, combined with the slow-release encapsulation method, will eventually command a worthwhile share of the agrochemical and several related markets.

An updated presentation from Eden at helps give a glimpse of the opportunities. Page eight lists Eden’s target markets and their size by 2020 – biopesticides (worth $6.9bn with Eden products to tackle botrytis, powdery and downy mildew, slug and snail treatment and mites and white flies); conventional pesticides ($76.8bn and Eden in co-encapsulated conventional synthetic pesticides and formulation delivery systems); and animal health ($33bn with Eden in companion animal flea and tick products, odour control, and ear, coat and skin care).

Eden simply has to scratch the surface of this stuff to suggest the current £23m market capitalisation is too modest. That explains why many subscribers have been ready to sit and wait while Eden moves towards becoming a real company. It has the patents (over 122 granted and pending), and is starting to hack a way through the regulatory forest, and picking up major name partners to finance and market product along the way. But, by golly, it takes time.

The half-year figures show that, at last, the possibilities are starting to translate into real sales. Revenue was up by £900,000 to just over £1m. Half of that came when Sipcam agreed an option and evaluation deal which would allow it first option on Eden ‘s plant protection products in certain markets. But revenues from 3AEY, Eden’s initial product for tackling botrytis in grapes, must have risen by some £400,000. Part of this was because of a switch which saw Eden producing and selling 3AEY instead of taking a royalty.

Unusual weather conditions – frost, then excessive heat and drought – have impacted sales through the summer, and while 3AEY has been very well received, it is impossible to predict second half sales firmly. Eden, though, accepts that the Shore annual revenue target of £1.7m makes sense.

Looking ahead, regulatory approval for 3AEY in France came late in the season, and Portugal has only just come through. All of the key European grape-growing countries are now in the fold, and there is a steady flow of label extensions, approving use on additional crops.

So there is a growing run of repeatable revenue from sales. And Sipcam option cash – perhaps a larger amount than this year - ought to chip in again in 2018 as Sipcam evaluates and picks up options to sell 3AEY in other areas. It is a global operator with sales approaching £1bn, and is linked to Japanese giant Sumitomo.

Crucially, the Sipcam partnership has eased financial pressures. At the half-year, Eden had cash of £3.66m. That is allowing it to take on more personnel, pursue more regulatory clearances, and generally advance the business. Shore Capital projects that £3.1m cash will remain at the end of the year. There are current trials on five continents, and registration applications are pending in 29 countries.

There could be significant new deals before the end of the year. Meanwhile work continues with US giant Eastman, and a nematicide is on track for launch in 29 countries. The long-awaited and oft-postponed launch of by Bayer of animal health products in the USA is expected in the first quarter of 2018. Even TerpeneTech might launch a head lice product early next year.

None of these new products and markets is built into the cautious broker forecasts, and could generate significant payments and then royalties. So the forecast figures almost certainly understate the potential value of Eden, and the labour and direct expense of pushing through regulatory approvals for Eden’s three key terpenes.
The broker takes a positive view of Eden, saying ‘We continue to believe Eden is well-placed with a growing and diverse product development pipeline in an industry that is seeing structural growth in demand for natural solutions. This is in the context of it getting harder to get product registrations for synthetic conventional pesticides which is a market with an overall value of over $57bn per year. So with higher barriers to entry we believe Eden can drive value creation going forward.’

A new chairman steps in on January 1. Hopefully he will have the experience and contacts to help drive Eden forward. He ought certainly to add credibility. Lykele van der Broek was former chief operating officer of Bayer Crop Science and former head of the animal health care division of Bayer Health Care. He is 60, and while he is aware of it, is not involved in the Eden animal health deal with Bayer. His arrival ought to be encouraging – at Bayer he would have had experience of running the biggest crop protection company in the world.

It all helps add to the possibilities in Eden. It is taking a long, long time to realise the potential of terpenes and encapsulation, but the agro-industry is governed by the seasons, and though it is tempting to think otherwise, big companies do not readily beat a path to small players with bright ideas. It is slog, slog, slog, especially given the heavy regulatory framework governing such areas (though it is hard to forgive the glacial pace at which this often moves).

Eden is staring to deliver product in the real world, but the attraction remains the potential. The vast scope for all-natural pesticides is increasingly recognised, but Eden’s terpenes might do so much more. Even now, with 3AEY for botrytis selling well in the early stages, there are many related applications yet to be exploited and vast areas of the world where no-one has yet picked up the distribution rights.

The theme will be familiar to subscribers Not this year, maybe next year, but give it time and Eden could be a big winner. Who knows? One of the giants might come to understand that, too.

I have a holding in Eden Research.

Ends

supersonico
10/12/2017
19:49
Increasing food security issues across the globe due to population outburst is further supporting the demand for bio pesticides in developing as well as developed nations. Major agrarian economies such as India, Brazil, etc., are extensively adopting sustainable crop protection products and pesticides in their farming methods, which is anticipated to drive the global bio pesticides market over the coming years.
The global bio pesticides market is projected to grow at a CAGR of more than 16% by 2026. The growth in the global bio pesticides market is expected on account of various promotional activities carried out by government agencies and groups to replace the hazardous and expensive synthetic pesticides with environment-friendly and inexpensive substitutes.

supersonico
10/12/2017
19:31
“There’s no reason food companies should look overseas when the best farmers in the world are right here in Pennsylvania,” Casey said in a news release. “As demand for organic products grows, we must do all we can to help American farmers and ranchers meet this demand.
supersonico
09/12/2017
00:35
Date: Nov 22, 2017
Location: Merelbeke, BE
Global Marketing Director, Crop Protection
Ghent, Belgium

Do you possess strong strategic and thought leadership capabilities combined with deep knowledge of the Crop Protection industry? Welcome to Eastman Chemical Company…

This is Eastman Chemical Company
Eastman is a global specialty chemical company that produces a broad range of products found in items people use every day. With a portfolio of specialty businesses, Eastman works with customers to deliver innovative products and solutions while maintaining a commitment to safety and sustainability. Our market-driven approaches take advantage of world-class technology platforms and leading positions in attractive end-markets such as transportation, building and construction, and consumables. Eastman focuses on creating consistent, superior value for all stakeholders. As a globally diverse company, Eastman serves customers in approximately 100 countries and had 2016 revenues of approximately $9 billion. The company is headquartered in Kingsport, Tennessee, USA and employs approximately 15,000 people around the world.

This is the role
The Global Marketing Director is responsible for developing the marketing strategy for Crop Protection. You share responsibly with other directors and marketing managers to ensure in-depth marketing tools and techniques are developed and applied to all growth projects. You are a strategic stakeholder for the business organization and innovation platforms. You ensure optimal insights in end-markets and applications are included when developing business strategies, scoping growth initiatives, and leading market facing growth projects.

supersonico
09/12/2017
00:22
Lykele van der Broek, Chairman designate, commented: "I have watched the commercial progress that Eden has made in recent years and am delighted to be joining the Company and to taking over from Tom in 2018. This is a very exciting period for Eden and I look forward to helping develop the business further."

Background

Mr. Lykele Jurrit van der Broek served as the Member of the Management Board at Bayer CropScience of Bayer HealthCare AG since November 1, 2010. Mr. Van Der Broek has over 30 years of experience in the agriculture sector. Mr. Van Der Broek served as Head of Market Strategy at Bayer CropScience AG until June 30, 2014. He served as the Chief Operating Officer of Bayer CropScience AG since November 1, 2010 and served as its Head of Agricultural Commercial Operations from November 01, 2010 to December 31, 2013. He served as the President/Head of Animal Health Division of Bayer HealthCare AG of Bayer CropScience AG from October 1, 2006 to November 2010 and was responsible for the Animal Health Division. From 1984 to 1991, Mr. Van Der Broek acted as Deputy Director and Director of the Netherlands Inspection Service for Arboriculture (NAKB). He then served different positions in BioScience companies. On joining Nunza (now Nunhems), a vegetable seed group, in 1999, he was responsible for Asia Pacific and strategy. Since 2001, he served as the Chief Executive Officer and continued this position after Bayer's the acquisition of Aventis CropScience in 2002. Since 2003, he served as Head of BioScience, a business group within Bayer CropScience, before changing into the position as Head of Regional Coordination Europe at Bayer AG. Mr. Van Der Broek started his career at the Plant Protection Service of Netherlands. He has been Non-Executive Director of Eden Research PLC since October 01, 2017. Mr. Van Der Broek has been a Non-Executive Director at Genus plc since July 1, 2014. He serves as a Director of Peertje voor de Dorst B.V. He served as a Director of Bayer CropScience AG. He is graduated from the Agricultural University in Wageningen (Netherlands) with a Master of Science specializing in Phytopathology and Business Administration.

supersonico
08/12/2017
19:40
Interesting interview with Rick Rule.. He identifies Agriculture as a strong growth sector, a view shared by Powerscourt who are growing their footprint in the Produce/agricultural sector.
supersonico
06/12/2017
15:37
Sumi Agro keeping the Tweets coming..

Eden Research plc Retweeted

Sumi Agro France‏
@SumiAgroFrance
22h
22 hours ago

La nature est bien faite! En conditions sèches, les parois des levures qui contiennent les 3 #terpènes de #Mevalone notre solution de #biocontrole anti #botrytis sont rétractées. En conditions humides, propices au botrytis, elles se gonflent et libèrent les #terpènes. Malin !
Translated from French by
Bing
Nature is well done! In dry conditions, the walls of the yeast that contain the 3 #terpènes of #Mevalone our anti #botrytis #biocontrole solution are retracted. In wet conditions conducive to botrytis, they swell up and release the #terpènes. Smart!

supersonico
04/12/2017
18:01
Think I will get the lovely lady one of those anti- boryitis packs for Xmas instead of the usual Clarins
hillofwad
04/12/2017
16:23
4 Terpenes details @ Sumiagro/ L'association de 4 terpènes dans un pack





Terp'Innov IV, anti-botrytris pack
Terp'innov IV is a pack that combines Nirka, a biocontrol anti-botrytis composed of three terpenes, with Adjuvant Base M, a terpenes adjuvant that works in synergy with Nirka and improves its duration of action and its fungicidal properties. . Terp'innov IV is:
enhanced efficiency,
an optimized spray quality,
reduced doses of Nirka,
a respected environment,
comfort of use

Nirka, anti-botrytis biocontrol, is composed of three terpenes: thymol, eugenol, geraniol. These molecules, very volatile, are naturally present in the plant world. Nirka's innovation lies in its patented terpenes microencapsulation system that helps stabilize them. The yeast walls ensure a gradual release of these terpenes and thus improve their persistence of action

supersonico
04/12/2017
11:41
EU agriculture needs a clearer direction towards long-term sustainability "

Brussels (BE), 11/29/17 - The European Commission adopted a "Communication" on the Future of Food and Agriculture. The aforementioned Communication, was presented to the EU institutions, establishes the orientation of the EU for the future Common Agricultural Policy (CAP).
The next reform of the CAP is a great opportunity to promote a total transition towards more sustainable agriculture in Europe. Today's Communication offers some possibilities for improvement, however, it lacks a clear and common EU approach to realize the broader intentions of the Commission to move towards more sustainable growth models in the next EU budget. (1) Nor does it prioritize the expansion of sustainable agricultural systems, such as organic farming (EA), which can help lead the way towards an ambitious implementation of the United Nations Sustainable Development Goals in the European agricultural sector by both the EU as per the Member States.

Christopher Stopes, President of IFOAM EU said: "With a CAP representing almost 40% of EU spending and the Commission proposing a more results-oriented budget after 2020, it can no longer be justified to spend money in support of income to a large extent, with limited impact. To have the full confidence of EU citizens, we must maintain a common approach throughout the EU. EU leaders must ensure in future discussions of the EU budget that future CAP payments are based on farmers offering a wide range of public goods based on a comprehensive agricultural system approach. "
In the current CAP, producer income support (Pillar 1) is conditional on meeting basic sustainability requirements and is 100% funded by the EU, and farmers who want to go one step further (such as organic) have only the option to undertake more ambitious voluntary schemes under Pillar 2 (which are co-financed by the EU). If the current structure is maintained, the next reform runs the risk of maintaining the status quo and not giving the necessary impetus to prioritize sustainability.

Jan Plagge, Vice President IFOAM EU: "Today most farmers are at the mercy of the big players in the industry in an increasingly globalized market, and they lack incentives to change their productive orientation in a more sustainable sense. EU policy makers should use the upcoming CAP reform to send a clear signal that sustainability should be the center of the European agri-food sector. To this end, the next legislative proposals should make concrete efforts to completely link support to agricultural income with the contribution of a wide range of public goods, based on reward and incentive, 100% financed by the EU budget. " (2)
Mrs A. Calafat, of the Directive of the Spanish Society of Ecological Agriculture (SEAE) and representative of the Spanish organic farmers in IFOAM EU, is aligned with this position of orienting the CAP towards the agrarian sustainability.

supersonico
03/12/2017
19:55
Month 2 gone in the 'coming months' narrative.

...................................................


supersonico - 26 Nov 2017 - 13:53:31 - 2932 of 2944
Eden Research - EDEN
Longtime coming News

According to the Half year report of 29/9/17

Will Mr Smiths announcements meet Supersonico expectations?

Mr Smith says 'the outcome of these discussions will be announced in the coming months'. ;
Supersonico expects..Oct/nov/dec17 / jan18.

Mr Smith says 'launch of its head-lice treatment product in early 2018'
Supersonico expects jan / feb / mar18

supersonico
29/11/2017
15:22
Action Pin and Sumiagro presenting at Sitevi 17 wine industry show.

Interesting company with wide overlap in products to Eden and looks like there fungicide is being promoted with Mevalone by Sumiagro.. 3+1 terpenes, although a quick glance at the Action pin web site did not throw up any info on their use of Terpenes. Their Crop protection page is under construction..so it maybe there or they just don't advertise the fact.

Possible Encapsulation opportunities?
Also product overlap with Rob Cridlands company

supersonico
29/11/2017
11:29
ABIM 2017: The biggest gathering of biocontrol professionals ever.



Lucius Tamm from ABIM co-organisers, the Research Institute for Organic Agriculture (FiBL), in his welcoming address, pointed to the enormous growth of organic farming worldwide: While only 11 million hectares of crops were grown organically globally in 1999, the figure has grown to 50 million hectares last year; a fivefold increase in in just 17 years. "Organic agriculture has the strongest growth in agriculture," emphasized Tamm, “but we are pleased to report, that biocontrol solutions have now even a much bigger market in conventional agriculture than in the booming organic sector!” he added.

supersonico
28/11/2017
18:01
Sumiagro promoting Mevalone @ Wine Industry Exhibition #SITEVI 2017
supersonico
Chat Pages: Latest  142  141  140  139  138  137  136  135  134  133  132  131  Older

Your Recent History

Delayed Upgrade Clock